Importance of “first-pass elimination” for interindividual differences in steady-state concentrations of the adrenergicβ-receptor antagonist alprenolol
- 1 May 1977
- journal article
- conference paper
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 5 (3), 193-205
- https://doi.org/10.1007/bf01065395
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Stoichiometric Interaction of a β‐Receptor Blocking Drug with Fraction of Liver Cytochrome P‐450 as a Possible Cause for its Dose‐dependent AvailabilityActa Pharmacologica et Toxicologica, 1976
- The Possible Role of Cytochrome P‐450 in the Liver “First Pass Elimination” of a P‐Receptor Blocking DrugActa Pharmacologica et Toxicologica, 1974
- Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in manLife Sciences, 1974
- Effect of route of administration on drug dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Transport and Binding of Methotrexate In VivoJournal of Pharmaceutical Sciences, 1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Prediction of systemic availability from plasma-level data after oral drug administrationJournal of Pharmacy and Pharmacology, 1973
- Relationship between Dose and Plateau Levels of Drugs Eliminated by Parallel First-Order and Capacity-Limited KineticsJournal of Pharmaceutical Sciences, 1972
- The Disposition of PropranololPharmacology, 1972
- Physiological and Pharmacokinetic Complexities in Bioavailability TestingPharmacology, 1972